Reports for PAPAVERINE HYDROCHLORIDE INJECTION USP
Brand name
PAPAVERINE HYDROCHLORIDE INJECTION USP
Company Name
SANDOZ CANADA INCORPORATED
|
Drug Identification Number
00009881 |
Ingredients
PAPAVERINE HYDROCHLORIDE |
Ingredient Strength
65 MG |
ATC Code
A03ADA03AD |
ATC Descriptor
DRUGS FOR FUNCTIONAL BOWEL DISORDERS DRUGS FOR FUNCTIONAL BOWEL DISORDERS |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
PAPAVERINE HYDROCHLORIDE INJECTION USP | 2ML 10LIVI | Resolved | 2022-04-06 | 2022-09-27 | 158046 |
PAPAVERINE HYDROCHLORIDE INJECTION USP | 2ML | Resolved | 2022-12-28 | 2023-03-14 | 179515 |
PAPAVERINE HYDROCHLORIDE INJECTION USP | 2ML 10LIVI | Resolved | 2023-12-19 | 2024-01-06 | 213882 |
Showing 1 to 3 of 3
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0